Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
HYAL1,Hyaluronidase-1,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,Inverse variance weighted,23,1.07 [1.01-1.12],0.0142314617828143
HYAL1,Hyaluronidase-1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,23,1.06 [1.01-1.10],0.019490252987854
HYAL1,Hyaluronidase-1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,23,1.04 [1.00-1.08],0.0253803736016028
HYAL1,Hyaluronidase-1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,Inverse variance weighted,23,1.04 [1.01-1.07],0.0065879376650892
HYAL1,Hyaluronidase-1,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,23,1.05 [1.00-1.10],0.0383042106931009
HYAL1,Hyaluronidase-1,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,23,1.04 [1.01-1.08],0.0235714233597981
HYAL1,Hyaluronidase-1,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,Inverse variance weighted,23,1.08 [1.01-1.15],0.018758764427267
HYAL1,Hyaluronidase-1,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,23,1.04 [1.01-1.08],0.0153603237984497
HYAL1,Hyaluronidase-1,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,23,1.08 [1.00-1.17],0.0467785551626566
